期刊文献+

全身热疗对全凭静脉麻醉下阿曲库铵肌松效应的影响

The effects of whole-body hyperthermiaon pharmacodynamics of atracurium under total intravenous anesthesia
原文传递
导出
摘要 目的 观察全身热疗(whole body hyperthhermia,WBH)对晚期癌症患者全凭静脉麻醉(total intravenous anesthesia,TIVA)中阿曲库铵用量和作用时间的影响。方法 晚期癌症TIVA患者,分非高温组(24例),高温组(26例)。监测两组患者的体温、心电图(ECG)、中心静脉压(CVP)、脉搏血氧饱和度(SpO2)、pH值,呼气末二氧化碳分压(PEIcO2)等;记录各组阿曲库铵用量。监测停止输注阿曲库铵时,4个成串刺激(train of four,TOF)从10%恢复至25%、50%、75%平均时间。结果 与非高温组阿曲库铵用量(73.2±9.5)mg/kg、平均泵速(5.1±O.9)μg·kg^-1·min^-1比较,高温组阿曲库铵用量为(123.8±15.7)mg/kg VS(73.2±9.5)mg/kg(P〈O.01),平均泵速(12.5±1.7)μg·kg^-1min^-1vs(5.1±0.9)μg·kg^-1·min^-1(P〈O.01)。非高温组,TOF从10%恢复至25%、50%、75%的时间分别为(8.2±2.5)min,(13.8±2.3)min,(24.1±3.7)min;高温组,TOF从10%恢复至25%、50%、75%的时间分另0为(4.8±1.3)minVS(8.2±2.5)min(P〈0.01),(8.6±1.7)minVS(13.8±2.3)min(P〈0.05),(14.1±3.2)minVS(24.1±3.7)min(P〈0.01).结论 WBH可以增加晚期癌症患者TIVA中阿曲库铵的用量和输注速度,缩短其作用时间。 Objective To observe the effects of whale-body hyperthermia (WBH)on pharmacodynamics of atracurium in patients with malignant tumor under total intravenous anesthesia. Methods Fifty patients with advanced cancer were randomly assigned into two groups, hyperthermia group (n=24)and non-hyperthermia group (n=26). Parameters such as body temperature, electrocardiogram(ECG), central venous pressure (CVP), pulse oxygen saturation (SpO2)and endridal CO2(PETCO2) were monitored during the operation. The train of four (TOF) mode of stimulation was used to monitor neuromuscular blocking. The dosages of atracurium were recored. The TOF on the time of atracurium withdrawal and the time of 25 %, 50 %, 75 % recovery from 10% of TOF were recorded. Results The dosage of atracurium in hyperthermia group was higher than that of non hyperthermia group (123.8±15.7) mg/kg vs (73.2±9.5) mg/kg(P〈O.O1 ). The infusion speed of atracurium in hyperthermia group was faster than that of non hyperthermia froup (12.5±1.7) μg^-1kg^-1min^-4 vs (5.1±0.9) μg'kg^-l.min^-1(P〈O.O1). The 25%, 50%, 75% of TOF recovery from 10% of TOF in non- hyperthermia group were (8.2±2.5), (13.8±2.3), (24.1±3.7) min, respectively. The 25% ,50%,75% of TOF recovery from 10% of TOF in hyperthermia group were(4.8±l.38),(6±l.7),(14.1±3.2), respectively. Conclusion WBH increases the consumption and infusion speed of atracurium and shortens the acting time of atraeurium.
出处 《国际麻醉学与复苏杂志》 CAS 2011年第3期277-280,共4页 International Journal of Anesthesiology and Resuscitation
基金 徐州市社会发展基金
关键词 全身热疗 阿曲库铵 4个成串刺激 全凭静脉麻醉 Whole-body hyperthermia Atracurium TOF Total intravenous anesthesia
  • 相关文献

参考文献13

  • 1Kerner T,Deja M,Ahlers O,et al.Monitoring arterial blood pressure during whole body hyperthermia.Acta Anaesthesiol Scand,2002,46(5):561-566.
  • 2Hall DM,Baumgardner KR,Oberley TD,et al.Splanchnic tissues undergo hypoxic stress during whole body hyperthermia.Am J Physiol,1999,276(5 Pt 1):1195-1203.
  • 3Kerner T,Deja M,Ahlers O,et al.Whole body hyperthermia:a secure procedure for patients with various malignancies?Intensive Care Med,1999,25(9):959-965.
  • 4Kemer T,Hildebrandt B,Ahlers O,et al.Anaesthesiological experiences with whole body hyperthermia.Int J Hyperthermia,2003,19(1):1-12.
  • 5Meyer RE,Page RL,Thrall DE,et al.Determination of continuous atracurium infusion rate in dogs undergoing whole -body hyperthermia.Cancer Res,1986,46(11):5599-5601.
  • 6Robins HI,Rushing D,Kutz M,et al.Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.J Clin Oncol,1997,15(1):158-164.
  • 7Robins HI,Cohen JD,Schmitt CL,et al.Phase Ⅰ clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.J Clin Oncol,1993,11(9):1787-1794.
  • 8夏冬,冯智英,陈庆廉,金旭东.全身麻醉下全身热疗对肿瘤患者血流动力学、血气的影响[J].浙江医学,2004,26(12):933-934. 被引量:2
  • 9姚冰薇,王桂龙,王军.全身麻醉50例体温变化对阿曲库铵肌松效应的影响[J].南通大学学报(医学版),2005,25(6):467-467. 被引量:2
  • 10杨贵英,闵苏.不同体温对兔不同剂量顺式阿曲库铵肌松效应的影响[J].中华麻醉学杂志,2008,28(9):800-803. 被引量:5

二级参考文献29

  • 1孙瑗,王祥瑞.温度对于肌松药的影响[J].国外医学(麻醉学与复苏分册),2004,25(6):347-350. 被引量:7
  • 2杨晋祥,金志强,张安飞.阿曲可林在低温体外循环心内直视术麻醉中药效与药动学研究[J].中华麻醉学杂志,1995,15(3):139-139. 被引量:4
  • 3徐叔云 卡如濂 陈修.药理试验方法学 第2版[M].北京:人民卫生出版社,1991.693.
  • 4Jauchem JR. The role of autacoids and the autonomic nervous system incardiovascular responses to radio-frequency energy heating. Auton Autacoid Pharmacol, 2006, 26: 121-140.
  • 5Cammu G, Coddens J, Hendrickx J, et al. Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass. Br J Anaesth, 2000, 84: 587-590.
  • 6Bruns I, Kohlmann T, Wiedemann GJ, et al. Evaluation of the therapeutie benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS). Pneumologie, 2004, 58: 210-216.
  • 7Leslie K, Sessler DI, Bjorksten AR. Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg, 1996, 82:426.
  • 8Meyer RE, Page RL, Thrall DE, et al. Determination of continuous atracurium infusion rate in dogs undergoing whole-body hyperthermia. Cancer Res, 1986, 46: 5599-5601.
  • 9Cammu G, Boussemaere L, Foubert J, et al. Large bolus dose vs. continuous infusion of cisatracurium during hypothermic cardiopulmonary bypass surgery. EurJ Anaesthesiol, 2005, 22: 25-29.
  • 10Huhstrom M, Jansson L, Bodin B, et al. Moderate hypothermia induces a preferential increase in pancreatic islet blood flow in anesthetized rats. Am J Physiol Regul Integr Comp Physiol, 2007, 293:R1438-R1443.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部